Related references
Note: Only part of the references are listed.Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studies
Mladen Vassilev Tzvetkov et al.
PHARMACOGENOMICS (2010)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Determinants of steady-state torasemide pharmacokinetics - Impact of pharmacogenetic factors, gender and angiotensin II receptor blockers
Dierk Werner et al.
CLINICAL PHARMACOKINETICS (2008)
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1
Gustav Ahlin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Drug therapy: Chemotherapy-induced nausea and vomiting
Paul J. Hesketh
NEW ENGLAND JOURNAL OF MEDICINE (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)
Anne T. Nies et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele*3 independently affect torsemide pharmacokinetics and pharmacodynamics
S. V. Vormfelde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines
Constanze Hilgendorf et al.
DRUG METABOLISM AND DISPOSITION (2007)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Organic cation transporters are determinants of oxaliplatin cytotoxicity
Shuzhong Zhang et al.
CANCER RESEARCH (2006)
Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype
PK Janicki et al.
ANESTHESIA AND ANALGESIA (2006)
In vitro basis for schedule-dependent interaction between gemcitabine and topoisomerase-targeted drugs in the treatment of colorectal cancer
S. N. Richter et al.
ANNALS OF ONCOLOGY (2006)
Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation
G Ciarimboli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The impact of pharmacogenomics on postoperative nausea and vomiting - Do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
KA Candiotti et al.
ANESTHESIOLOGY (2005)
5-HT3-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment
M Aapro
ONCOLOGY (2005)
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future
M Ingelman-Sundberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1
Y Shu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences
R Kerb et al.
PHARMACOGENETICS (2002)
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes
R Kaiser et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection
S Bauer et al.
BIOMEDICAL CHROMATOGRAPHY (2002)
Share Paper
